The Tiantan Cerebrovascular Disease Center is patient-centered and integrates the clinical treatment resources of several advantageous disciplines such as neurosurgery, neurology, neurointervention, emergency intervention, imaging, intensive care, neurorehabilitation, and emergency medicine to construct a strong medical team for cerebrovascular disease and continuously improve the quality of clinical treatment for cerebrovascular disease, and the center also has a strong epidemiological management, basic research, and basic and clinical application research platforms such as cerebrovascular disease drug development. Within this center, medical practice, research and training are integrated into a trinity, divided into clinical, research, imaging and academic training departments. Liu Aihua, Department of Neurosurgery, Beijing Tiantan Hospital
Clinical Department: Composed of five backbone departments and departments of outpatient and emergency medicine and neurological rehabilitation, each ward admits different types of patients. For different conditions, the center adopts a personalized treatment plan for each patient on the basis of a comprehensive assessment. Patients with cerebrovascular disease can truly enjoy the one-stop holistic service of green channel and multidisciplinary joint diagnosis and treatment in it.
1.Thrombolytic treatment of ischemic cerebrovascular disease
Thrombolytic therapy within the 3-9 hour time window for ischemic cerebrovascular disease is currently the most effective treatment to improve the outcome of acute ischemic stroke. The Titan Cerebrovascular Disease Center upholds the concept that time is brain and integrates the emergency department of neurology, neuroimaging department, cerebrovascular disease ward and monitoring room to establish a green channel for thrombolysis, taking advantage of the team to optimize the thrombolysis pathway and provide safe and effective treatment for acute ischemic stroke patients.
2.Green channel for subarachnoid hemorrhage
Early treatment of the cause of subarachnoid hemorrhage (aneurysm) after the onset is the key to the treatment effect. Titan Cerebrovascular Disease Center integrates neurological and surgical emergencies, emergency rescue room, neuroimaging department, neurointervention, vascular neurosurgery and cerebrovascular disease care unit to establish a green channel for subarachnoid hemorrhage, optimize the treatment pathway, provide timely and appropriate treatment for patients with the strength and collaborative spirit of team medicine, and improve the level of treatment for subarachnoid hemorrhage.
3.Stent intervention for ischemic cerebrovascular disease
The interventional ward of ischemic cerebrovascular disease in Tiantan Cerebrovascular Disease Center has made continuous efforts to pursue excellence, and has successfully performed more than 500 cases of internal stenting for intracranial arterial stenosis and more than 2,000 cases of internal stenting for stenosis of extracranial cerebral blood supply arteries. In addition, we have also performed emergency endovascular treatment for acute ischemic stroke (such as intra-arterial drug thrombolysis and emergency intra-arterial stenting treatment) and interventional treatment for cerebral vein and venous sinus thrombosis. Among them, the stenting treatment of intracranial artery stenosis is at the international advanced level, which has won the recognition of experts in the field of neuroscience and the praise of patients, and has gained good social benefits. 3. Stent intervention for ischemic cerebrovascular disease
The interventional ward of ischemic cerebrovascular disease in Tiantan Cerebrovascular Disease Center has made continuous efforts to pursue excellence, and has successfully performed more than 500 cases of internal stenting for intracranial arterial stenosis and more than 2000 cases of internal stenting for stenosis of extracranial cerebral blood supply arteries. In addition, we have also performed emergency endovascular treatment for acute ischemic stroke (such as intra-arterial drug thrombolysis and emergency intra-arterial stenting treatment) and interventional treatment for cerebral vein and venous sinus thrombosis. Among them, the stenting treatment of intracranial artery stenosis is at the international advanced level, which has won the recognition of experts in the field of neuroscience and the praise of patients, and has gained good social benefits.
4.Interventional treatment of hemorrhagic cerebrovascular disease
The interventional ward of hemorrhagic cerebrovascular disease in Tiantan Cerebrovascular Disease Center has successfully embolized more than 6,000 cases of various cerebral and spinal cord vascular diseases, and has undertaken national research projects for many times, and has accumulated rich experience in the research of clinical application of new cerebrovascular interventional techniques and the development of embolization materials for endovascular treatment. We have achieved a leap from excellence to excellence.
5.Neurosurgical treatment of cerebrovascular disease
The surgical ward of Tiantan Cerebrovascular Disease Center implements the “minimally invasive concept”. It carries out surgical treatment of intracranial aneurysm, vascular malformation, atherosclerotic cerebral ischemia and smog, and other hemorrhagic and ischemic cerebrovascular diseases. We actively introduce innovative technologies to minimize the damage caused by the surgery itself, including intraoperative cerebral angiography, neuronavigation, intraoperative ultrasound, cerebral blood flow monitoring, intraoperative electrophysiological monitoring, etc. While treating diseases, we minimize the occurrence of postoperative complications and improve the quality of patients’ survival; on the other hand, we effectively shorten the hospitalization time and speed up the turnover to meet the needs of more patients. needs.
6.Neurology treatment of cerebrovascular disease
The cardiovascular and cerebrovascular disease ward of Tiantan Cerebrovascular Disease Center conducts a comprehensive evaluation of each patient admitted to the center and provides evidence-based, uniformly standardized, yet individualized drug treatment along with corresponding psychological, speech, swallowing function and limb rehabilitation treatment. Inpatients and their family members not only receive health education during hospitalization, but also have professional physicians and nurses to follow up with them by phone for daily guidance and answering questions after discharge.
7.Critical care, the weight of life
The intensive care ward of Tiantan Cerebrovascular Disease Center has a good environment, advanced monitoring facilities and solid technology. It carries out arterial puncture, central venous placement, hematoma fragmentation aspiration, ventricular puncture and volume monitoring technology, and is able to perform intracranial pressure, central venous pressure, invasive arterial pressure, as well as EEG and TCD monitoring. The intensive care unit pays full attention to collaborative team medicine and cooperates with the center’s cerebrovascular disease ward, neurosurgery ward, ischemic cerebrovascular disease interventional ward and hemorrhagic cerebrovascular disease interventional ward to escort and support the mission of intensive care life.
Imaging Department: The imaging department of Tiantan Cerebrovascular Disease Center is based on cerebrovascular disease and has routinely carried out blood flow monitoring and vascular evaluation of TCD and vascular ultrasound to guide the clinical diagnosis and treatment of cerebrovascular disease. CT perfusion imaging, MR perfusion imaging, and diffusion-weighted imaging are carried out in the emergency department to analyze the ischemic semidark zone to guide clinical thrombolytic treatment. It also explores the role of magnetic sensitivity weighted imaging, diffusion tensor imaging and functional imaging in the prognosis and rehabilitation of cerebrovascular diseases, reflecting the spirit of relentless pursuit of advanced medical technology.
Research Department: The Research Department of the Cerebrovascular Disease Center of Tiantan Hospital carries out clinical and basic research with the thinking of translational medicine, and achieves organic unification of the two, forming an obvious collegial characteristic of combining clinical and scientific research. It has vigorously developed relevant basic laboratory work in scientific research, laying a solid research foundation for the sustainable development of the Cerebrovascular Disease Center.
The clinical research part is part of the Cerebrovascular Disease Clinical Trial and Clinical Research Center, the National Cerebrovascular Innovative Drug Clinical Evaluation Platform, and the Cerebrovascular Disease Phase I Clinical Trial Ward. The basic research department is composed of the management of cerebrovascular disease sample bank, cerebrovascular disease genome and proteome research laboratory, and cerebrovascular disease pathophysiology research laboratory.
Training Department: With the organizing committee of Tiantan International Cerebrovascular Disease Conference, China Stroke Journal, Stroke Prevention and Control Committee of Chinese Society of Preventive Medicine and Cerebrovascular Disease Training Center as solid communication platforms, it fulfills the mission of disseminating stroke information.